Brainstage Founder Co-Authors to W3C Paper

The World Wide Web Consortium (W3C) Semantic Web Health Care and Life Sciences Interest Group has published a paper on its work titled "Advancing translational research with the Semantic Web" in BMC Bioinformatics.  Brainstage's founder and CSO was one of the paper's co-authors.

The paper identifies a major barrier to translational research as the lack of uniformly structured data across related biomedical domains and it identifies ways in which the Semantic Web and emerging technologies combine to support identifying, representing, and reasoning across a wide range of biomedical data.

Brainstage Research is a member of the W3C and a participant in the W3C Semantic Web Health Care and Life Sciences Interest Group.

About Brainstage

Brainstage provides a Web-based platform that helps pharmaceutical and drug research companies accelerate the drug selection process, reduce the cost of preclinical and clinical studies, and increase the overall chance of success.  Brainstage’s platform tools give instant insight into new discoveries by tapping into the real-time data flow from around the world to synthesize meaningful relationships, create visual representations, and integrate them into daily work processes.  For more information, visit http://www.brainstage.com.